Porphyria cutanea tarda in a patient with post-transplant MDS.
We report a case of porphyria cutanea tarda associated with myelodysplastic syndrome in a patient after high-dose chemotherapy and peripheral blood stem cell transplantation for recurrent non-Hodgkin's lymphoma.
Oubre
D
D
Section of Hemlatology/Oncology, Department of Internal Medicine, Comprehensive Cancer Center of Wake Forest University, Winston-Salem, NC 27157, USA.
Cruz
J
J
Keung
Y
Y
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects* / Q000627:therapeutic use; D005260:Female; D018380:Hematopoietic Stem Cell Transplantation / Q000009:adverse effects*; D006801:Humans; D008228:Lymphoma, Non-Hodgkin / Q000473:pathology / Q000628:therapy*; D008875:Middle Aged; D009190:Myelodysplastic Syndromes / Q000209:etiology*; D017119:Porphyria Cutanea Tarda / Q000209:etiology*; D012008:Recurrence; D014182:Transplantation, Autologous